Clinical Trials Browser

INDUSTRY × vactosertib × Clear all

NCT05588648 2025-04-10

Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma

Phase 1/2 Recruiting

Osteosarcoma

NCT04515979 2024-12-09

Vactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung